Celery Seed for Metabolic Syndrome
Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
Recruiting
Phase 2
Interventional Study
Metabolic Syndrome
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 30 – 60
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 28 (estimated)
- Sponsor
- University of Guadalajara · Other
Who this trial is looking for
This trial is looking for people to test if celery seed can help with metabolic syndrome. Participants will need to meet specific health criteria and will be monitored over time.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 30 and 60 years old
- I have been diagnosed with metabolic syndrome
- I have a waist size of at least 80 cm (women) or 90 cm (men)
- My fasting glucose is less than 126 mg/dL
- My body mass index is between 25 and 34.9
- I have had stable weight for the last 3 months
- I have not been taking any medication for metabolic syndrome
- I agree to participate and sign the consent form
You may not be able to join if
- I am pregnant or breastfeeding
- My total cholesterol is 240 mg/dL or higher
- My triglycerides are 500 mg/dL or higher
- My systolic blood pressure is 140 mmHg or higher
- My diastolic blood pressure is 90 mmHg or higher
- I have a history of kidney, liver, or thyroid disease
- I take drugs or supplements that affect my metabolism
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Metabolic Syndrome (MS) is a cluster of cardiometabolic risk factors, which include abdominal obesity, hyperglycemia, dyslipidemia, and high blood pressure. MS is a global health problem, it represents a risk factor for the progression of cardiovascular disease, which constitute the main cause of mortality in the world and in Mexico. The current treatment involves lifestyle changes and pharmac…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients both sexes
* Age between 30 and 60 years
* Diagnosis of metabolic syndrome (MS) according to the IDF criteria: waist circumference: ≥80 cm (women) ≥90 cm (men), plus two or more of the following:
* Fasting glucose ≥ 100 mg/dL
* Triglycerides ≥150 mg/dL
* HDL-c:…
Contacts